Bengaluru, August 25, 2026: An Indian hair regeneration research platform with a rapidly expanding international footprint has added another intellectual property milestone with the grant of a new Indian patent. QR678®, whose products are used by a growing network of doctors across India and internationally, has received an Indian patent for an integrated hair growth system combining a shampoo, hair growth serum and nutraceutical supplements.

Bengaluru has become an important part of this journey, with more than 100 clinics in the city currently using QR678® related products. The development places Bengaluru within a much larger Indian and international story of research led innovation in hair regeneration.

The patent, titled “Kit for Promoting Hair Growth,” was granted on 24 July 2026 by the Indian Patent Office to Dr. Rinky Kapoor and Dr. Debraj Shome, Clinician Scientists and Research Mentors at QR678®.

What makes the latest development significant is the scale of the platform behind it. QR678® currently reports 22 published research papers, presence across 20+ countries and trust from more than 5,000 doctors worldwide, with more than 150,000 patients having been treated using QR678® driven products.

The QR678® research programme has also evolved into a broader product ecosystem. Multiple programmes have emerged from the underlying research platform, including QR678® NEO, QR678®PREO, QR678®ZEO and QR678® XPRO. The company is also developing multiple medical devices and pursuing drug development programmes while evaluating appropriate regulatory pathways for emerging technologies.

The new patent is part of an intellectual property journey that began more than a decade ago. QR678® received its first US patent for hair growth in 2017 and its first Indian patent in 2019. Further research, clinical studies and product development have continued to build on that foundation.

The clinical evidence behind the platform has also expanded. A multicentric clinical study led by Prof. René R. W. J. van der Hulst from the Netherlands evaluated QR678® Suite, QR678® NEO and their combination in 300 patients with early stage hair loss, including men and women, over six months.

The study reported significant improvements in hair growth, hair quality and scalp health. The QR678® NEO and QR678® Suite combination demonstrated the strongest outcomes, with the Global Hair Growth and Hair Quality Index increasing from 7.03 to 17.8. Its Follicular Revival Index increased from approximately 1.1 to 2.2, representing a reported 93.4% improvement.

QR678® has also expanded beyond India through international regulatory and commercial milestones. The company records MOH approval in Kuwait and other GCC countries and subsequent launch in the EU and UK.

Dr. Debraj Shome, Clinician Scientist and Research Mentor, QR678®, said: “Bengaluru has become an important part of our clinical footprint, but the larger story is what has happened to the research platform over time. What began with Indian research has evolved into patents, published clinical work, multiple products and an international presence. The next phase is about taking that scientific foundation into new products, devices and potential therapeutic pathways.”

Dr. Rinky Kapoor, Clinician Scientist and Research Mentor, QR678®, said: “Hair regeneration is moving towards a more integrated understanding of hair follicle and scalp biology. The latest patent is one part of that journey. Our continuing work across research, product development and emerging technologies is aimed at building a comprehensive platform rather than a collection of isolated products.”

For Bengaluru, the latest patent is therefore more than a corporate milestone. It connects the city’s growing network of QR678® clinics and dermatologists to a much broader Indian innovation story that now spans published research, patents, clinical evidence, products, international markets and the development of new generations of hair regeneration technologies.